VANCOUVER, Wash. — August 20, 2025 — Leads & Copy — Absci Corporation (Nasdaq: ABSI) will participate in investor conferences in September, including the Wells Fargo Healthcare Conference on Sept. 3, the Morgan Stanley 23rd Annual Global Healthcare Conference on Sept. 8, and the H.C. Wainwright 27th Annual Global Investment Conference on Sept. 9.
Interested parties can access live and archived webcasts of the Morgan Stanley and H.C. Wainwright Conference fireside chat sessions on the company’s investor relations website.
Absci is using generative design to create biologics for patients. Its Integrated Drug Creation™ platform combines AI models with a synthetic biology data engine to design therapeutics. Absci is headquartered in Vancouver, WA, with an AI Research Lab in New York City, and Innovation Center in Switzerland.
Investor Contact:
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact:
press@absci.com
Source: Absci
